Aspiriant LLC’s State Street SPDR Portfolio S&P 500 ETF SPYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$681K Buy
7,592
+15
+0.2% +$1.34K 0.02% 214
2026
Q2
$666K Sell
7,577
-70
-0.9% -$5.97K 0.02% 212
2026
Q1
$585K Sell
7,647
-776
-9% -$62.1K 0.02% 200
2025
Q4
$676K Buy
8,423
+2,727
+48% +$217K 0.02% 189
2025
Q3
$446K Buy
5,696
+1,442
+34% +$109K 0.01% 209
2025
Q2
$309K Buy
4,254
+109
+3% +$7.33K 0.01% 248
2025
Q1
$273K Buy
+4,145
New +$287K 0.01% 247

Other funds holding SPYM

Aspiriant LLC's SPYM Position: Q3 2026 in Review

Aspiriant LLC increased its State Street SPDR Portfolio S&P 500 ETF (SPYM) stake by 0.2% in Q3 2026, buying an estimated $1.34K and bringing the position to 7,592 shares worth $681K. The position accounts for 0.02% of the portfolio, ranked #214.

Aspiriant LLC first reported a position in SPYM in Q1 2025 and has held it in 7 quarters since. 481 funds tracked by Wall St. Rank hold SPYM as of Q3 2026.

  • Aspiriant LLC held 7,592 shares of State Street SPDR Portfolio S&P 500 ETF worth $681K as of Q3 2026.
  • Aspiriant LLC bought 15 State Street SPDR Portfolio S&P 500 ETF shares in Q3 2026, an estimated $1.34K.
  • State Street SPDR Portfolio S&P 500 ETF made up 0.02% of Aspiriant LLC's portfolio in Q3 2026, its #214 holding.
  • Aspiriant LLC first reported a position in State Street SPDR Portfolio S&P 500 ETF in Q1 2025 and has held it in 7 quarters since.
  • 481 funds tracked by Wall St. Rank held State Street SPDR Portfolio S&P 500 ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.